Article
Tumour cell binding by a human monoclonal IgM antibody from the spleen of a non-tumour-associated patient is due to somatic mutations in the VH gene.
Clinical and experimental immunology - 1 Mar 1995
Bohn J, Niemann B, Roggenbuck D, Döcke W, Jahn S
Abstract excerpt
Recently we described the occurrence of B cells producing polyspecific natural IgM with anti-tumour specificity in the spleen of non-tumour-bearing individuals as well as in fetal organisms. Immunoprecipitation and 2-D electrophoresis showed the binding of such antibodies to a 55-kD (pI 6.0) membrane surface glycoprotein. In vitro cultivation of human cancer cell lines in the presence of the purified IgM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
